830 related articles for article (PubMed ID: 6992895)
1. Oestrogens and endometrial hyperplasia.
Thom MH; Studd JW
Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
[TBL] [Abstract][Full Text] [Related]
2. The modifying effect of progestogen on the response of the post-menopausal endometrium to exogenous oestrogens.
Campbell S; McQueen J; Minardi J; Whitehead MI
Postgrad Med J; 1978; 54 Suppl 2():59-64. PubMed ID: 740582
[TBL] [Abstract][Full Text] [Related]
3. Progestogen deficiency and endometrial cancer risk.
Schindler AE
Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117
[TBL] [Abstract][Full Text] [Related]
4. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
5. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations.
Aylward M; Maddock J; Parker A; Protheroe DA; Ward A
Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584
[TBL] [Abstract][Full Text] [Related]
6. Estrogens, progestogens and endometrial cancer.
Gambrell RD
J Reprod Med; 1977 Jun; 18(6):301-6. PubMed ID: 196079
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of the endometrium.
Cavanagh D; Marsden DE; Ruffolo EH
Obstet Gynecol Annu; 1984; 13():211-60. PubMed ID: 6371616
[TBL] [Abstract][Full Text] [Related]
8. Sex steroids and cancer.
Gambrell RD
Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519
[TBL] [Abstract][Full Text] [Related]
9. Review of epidemiologic studies of endometrial cancer and exogenous estrogen.
Cramer DW; Knapp RC
Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641
[TBL] [Abstract][Full Text] [Related]
10. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
11. Endometrial pattern in patients with primary hypoestrogenic amenorrhea receiving estrogen replacement therapy.
Van Campenhout J; Choquette P; Vauclair R
Obstet Gynecol; 1980 Sep; 56(3):349-55. PubMed ID: 7422173
[TBL] [Abstract][Full Text] [Related]
12. Cancer and the use of estrogens.
Gambrell RD
Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
[TBL] [Abstract][Full Text] [Related]
13. Clinical considerations in the management of the menopause: the endometrium.
Whitehead MI; McQueen J; Minardi J; Campbell S
Postgrad Med J; 1978; 54 Suppl 2():69-73. PubMed ID: 740583
[TBL] [Abstract][Full Text] [Related]
14. Endometrial response to estrogen and progesterone therapy in patients with gonadal dysgenesis.
Benjamin I; Block RE
Obstet Gynecol; 1977 Aug; 50(2):136-8. PubMed ID: 876552
[TBL] [Abstract][Full Text] [Related]
15. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
Berger GS; Fowler WC
J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
17. The endometrium--from estrogens alone to TSECs.
Pickar JH
Climacteric; 2009 Dec; 12(6):463-77. PubMed ID: 19905899
[TBL] [Abstract][Full Text] [Related]
18. Association of exogenous estrogen and endometrial carcinoma.
Smith DC; Prentice R; Thompson DJ; Herrmann WL
N Engl J Med; 1975 Dec; 293(23):1164-7. PubMed ID: 1186789
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of progestins in the menopausal patient: dosage and duration.
Gambrell RD
J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
[TBL] [Abstract][Full Text] [Related]
20. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
Gambrell RD
Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
